A detailed history of Clearstead Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Clearstead Advisors, LLC holds 21,557 shares of SNY stock, worth $1.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,557
Previous 21,579 0.1%
Holding current value
$1.03 Million
Previous $1.05 Million 18.62%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$48.54 - $58.53 $1,067 - $1,287
-22 Reduced 0.1%
21,557 $1.24 Million
Q2 2024

Aug 09, 2024

BUY
$45.39 - $50.36 $940,208 - $1.04 Million
20,714 Added 2394.68%
21,579 $1.05 Million
Q1 2024

May 14, 2024

SELL
$45.75 - $52.48 $5,490 - $6,297
-120 Reduced 12.18%
865 $42,000
Q4 2023

Feb 12, 2024

BUY
$43.13 - $54.79 $18,114 - $23,011
420 Added 74.34%
985 $48,000
Q3 2023

Nov 07, 2023

SELL
$50.95 - $55.2 $14,011 - $15,180
-275 Reduced 32.74%
565 $30,000
Q2 2023

Aug 07, 2023

SELL
$50.45 - $57.18 $6,306 - $7,147
-125 Reduced 12.95%
840 $45,000
Q4 2022

Feb 14, 2023

BUY
$38.86 - $48.55 $9,948 - $12,428
256 Added 36.11%
965 $46,000
Q3 2022

Nov 14, 2022

SELL
$37.22 - $100.5 $2,977 - $8,040
-80 Reduced 10.14%
709 $27,000
Q2 2022

Aug 12, 2022

BUY
$48.99 - $57.46 $3,919 - $4,596
80 Added 11.28%
789 $39,000
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $15,297 - $17,013
325 Added 84.64%
709 $36,000
Q3 2021

Nov 12, 2021

SELL
$47.89 - $53.12 $7,758 - $8,605
-162 Reduced 29.67%
384 $19,000
Q2 2021

Aug 12, 2021

BUY
$49.36 - $54.25 $3,060 - $3,363
62 Added 12.81%
546 $29,000
Q4 2020

Feb 11, 2021

BUY
$45.3 - $51.62 $7,429 - $8,465
164 Added 51.25%
484 $24,000
Q1 2020

May 14, 2020

BUY
$38.02 - $51.66 $12,166 - $16,531
320 New
320 $14,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.